Wegovy
Wegovy and Hair Loss: Cause and Prevention
Wegovy shedding is real but often overstated. In the STEP 1 trial (Wilding et al.
Wegovy and Depression: Real Risk Profile
Introduction Wegovy®’s depression question has been one of the most-watched safety signals in obesity medicine since 2023, when Iceland’s regulator flagged a small cluster…
What to Do When UnitedHealthcare Denies Wegovy: Appeal Strategy
UnitedHealthcare processes pharmacy benefits through OptumRx, which is the same company under the UnitedHealth Group umbrella.
What to Do When Tricare Denies Wegovy: Appeal Strategy
Tricare denied your Wegovy prescription, and you want to know what is actually appealable and what is not.
Novo Nordisk Patient Support During Wegovy Shortage
Introduction Novo Nordisk operates several patient support programs that can help during Wegovy® supply gaps: NovoCare direct cash channel, savings cards for insured patients,…
What to Do When Medicare Denies Wegovy: Appeal Strategy
Medicare denying Wegovy is one of the most common and most fixable insurance problems in 2026.
What to Do When Medicaid Denies Wegovy: Appeal Strategy
Medicaid denials for Wegovy are common because anti-obesity medication coverage is optional under federal Medicaid rules.
What to Do When Kaiser Permanente Denies Wegovy: Appeal Strategy
Kaiser Permanente works differently than every other major insurer in this guide.
What to Do When Humana Denies Wegovy: Appeal Strategy
Introduction Humana’s book of business is heavily weighted toward Medicare Advantage and Medicare Part D, which means most Humana Wegovy® denials hit the same…
